Bayer has expanded functional supplements tailored for insulin resistance in this age group
The main difference is that, if skin laxity is a concern, the patient might be more interested in products that may help with mild skin laxity and textural changes
Preliminary research suggests it may influence incretin hormone pathways, though clinical evidence supporting meaningful GLP-1 or GIP enhancement in humans is lacking
Unless theres a specific short-term indication (recent stent, acute event), its time to go monotherapy
This reaction is severe and potentially life-threatening, including symptoms like unease, tingling, dizziness, itching, hives, swelling, difficulty breathing, and fainting
Jayne Hornung, chief clinical officer at Managed Markets Insight and Technology, suggests initial pricing of oral GLP-1s for weight loss could be reminiscent of the early days of anti-CGRP medications for migraines when the first oral CGRP came to market in 2019, the pricing still remained high
